NeuoroNesic Pain Relieving Cream
- Manufacturer
- Blaine Labs Inc.
- Effective date
- 2026-09-04
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- daily-update
- Hydrated at
- 2026-09-08 02:01:42
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
DRUG FACTS
Active Ingredients
Capsaicin ............ 0.1%
OTC - PURPOSE SECTION
Purpose ............... Topical Analgesic
INDICATIONS & USAGE SECTION
USES ■ For temporary relief from minor aches and pains of sore
muscles and joints associated with arthritis pain, simple backache,
strains and sprains ■ Provides warming pain relief
WARNINGS SECTION
Warnings- for external use only
Do not use: ■ on wounds or damaged skin with a heating pad
■ if allergic to capsicum or chili peppers
When using this produc: ■
test on a small area of skin before
first use to check for skin sensitivity ■ avoid contact with eyes or
mucous membranes ■ do not bandage tightly ■ do not expose area
to direct heat or direct sunlight ■ a slight burning sensation may
occur upon application and generally disappears within several days
Stop use and ask a physician if: ■ condition worsens
■ redness is present ■ symptoms persist for more than 7 days or
clear up and occur again within a few days ■ excessive skin
irritation develops
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.If swallowed, get medical help or
contact a poison control center (1-800-222-2222) immediately
DOSAGE & ADMINISTRATION SECTION
Directions
■
Adults and children 18 years of age and older:Apply to affected
area no more than 3 to 4 times daily. Wash hands with soap and
water after each use.
■
Children under 18 years of age:do not use, consult a physician.
OTHER SAFETY INFORMATION
Other Information
Store in a cool, dry place at 15º-30ºC (59º-86ºF).
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Alkyl (C12-15) Benzoate, Caprylyl Glycol, Carica Papaya (Papaya)
Fruit Extract, Carthamus Tinctorius (Safflower) Seed Oil, Cetyl Alcohol,
Dimethicone, Disodium EDTA, Emulsifying Wax, Ethylhexylglycerin,
Glycerin, Glyceryl Stearate, Hexylene Glycol, Hydrogenated
Polydecene, Hydroxyethyl Cellulose, PEG-100 Stearate,
Phenoxyethanol, Propylene Glycol, Purified Water, Sodium Lactate,
Sodium Polyacrylate, Trideceth-6, Xanthan Gum
NeuroNesic Label
----------------------------------------------
BLAINE LABS DISPENSED EXCLUSIVELY BY PHYSICIANS
NeuroNesic™
PAIN-RELIEVING CREAM
INGREDIENTS INCLUDE
PROPRIETARY BLEND OF
PAPAYA EXTRACT AND
SAFFLOWER SEED OIL
3.0 0Z (85.0 g)
MANUFACTURED BY: Blaine Labs, Inc.
11037 Lockport Place, Santa Fe Springs, CA 90670
MADE IN THE U.S.A
QUESTIONS OR COMMENTS?
(800) 307-8818 M-F 7:30AM - 4:00PM (PST)
RES
Products#
Every source-derived product name is available through these pages.
- NeuroNesic Pain Relieving Cream
- CAPSAICIN
- ALKYL (C12-15) BENZOATE
- CAPRYLYL GLYCOL
- PAPAYA
- CARTHAMUS TINCTORIUS (SAFFLOWER) SEED OIL
- CETYL ALCOHOL
- DIMETHICONE
- EDETATE DISODIUM
- POLAWAX POLYSORBATE
- ETHYLHEXYLGLYCERIN
- GLYCERIN
- GLYCERYL STEARATE
- HEXYLENE GLYCOL
- HYDROGENATED POLYDECENE (1500 CST)
- HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%)
- PEG-100 STEARATE
- PHENOXYETHANOL
- PROPYLENE GLYCOL
- WATER
- SODIUM LACTATE
- SODIUM POLYACRYLATE (8000 MW)
- TRIDECETH-6
- XANTHAN GUM
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 63347-999 | 63347-999-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NeuroNesic Pain Relieving Cream | CAPSAICIN | Blaine Labs Inc. | 7107c13d-bf59-4c0a-84fe-725a9fca2691 | 2026-09-04 | Warnings | 63347-999-01 63347-999 63347099901 5aab3dd9-6e8e-f16c-e063-6294a90a9644 7107c13d-bf59-4c0a-84fe-725a9fca2691 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
